Health2047 is a health IT firm based in San Francisco which is backed up the world largest healthcare firm the American Medical Association (AMA). The firm was started with an initial investment of $15 million. The head office of health2047 is based in Menlo Park. The firm aims to transform the 3 trillion healthcare to a system level. 

There are various healthcare problems, but health2047 is focusing on four major issues which need immediate solutions. The firm is providing solutions for data liquidity, chronic diseases, productivity and healthcare values. 

While focusing on data liquidity, health2047 started a new separate entity business known as Akiri Switch. Akiri switch uses the blockchain method to transmit secured data among healthcare providers and patients. It also encourages the use of a cloud-based system and Apps. Akiri switch was started with an initial investment of $10 million and was formerly known as Switch Co. 

Health2047 has launched its second spin out in 2018, known as First Mile Care. First Mile Care was started in response to the most growing chronic disease; diabetes.  To avoid diabetes 2, First-Mile care is coaching the patients online as well as offline. The firm will extend its services to part of the US. The firm was started with $2million. It is coaching more than 80% of the diabetes patient in the United States. 

To deal with the problems in productivity, health2047 is providing a unique platform for the physicians where they can easily share their ideas and knowledge and get involved in the innovation process. Health2047 is focusing on creating clinical tools and equipment to improve the healthcare sector. The firm has used the second round of funding for revamping the clinical tools.

The use of technology and electronic devices were not very common in the healthcare system, but now health2047 is convincing the physicians to use of technology in the workplace. To bring change in data liquidity, health2047 has collaborated with developed an early stage tech companies. 

This article explains the formation of health2047, its aims, and what they have delivered yet. Akiri switch and First Mile Care are the most significant achievements till now.

Celgene Corporation is a biotechnology business venture in the United States that is well known to develop and to commercialize medicines for inflammatory disease and other diseases like cancer.  Health2047 is a health IT business venture located in Silicon Valley and aims to transform the $3trillion healthcare industry to a system level. The firm is focusing on four major growing problems data liquidity, chronic diseases, productivity, and healthcare value. 

Health2047 has launched a separate entity known as Akiri switch in 2017. Akiri switch is using the blockchain method to transmit data among healthcare providers and patients. Health2047 has collaborated with health2047 to improve data liquidity and other problems; they are creating solutions, tools and commercializing those solutions to the public.

Celgene Corporation is developing and commercializing life-changing medicines for cancers and inflammatory diseases in the United States. Health2047 with the help of Celgene Corporation and developed tech companies has launched a network for secure data transmission among patients, physicians, hospitals, systems, payers, and research partners to provide useful healthcare model.

It was estimated that physicians spent more than 75% of his time in filing documents and files whereas only 15 to 20 % in listening and dealing with the patients. Health2047 and Celgene are promoting the use of technology in the healthcare sector and trying to improve data liquidity. Having a proper network will help the physicians to provide more time and interest to the physicians. 

Celgene Corporation has a unique relationship with the founding partner of helath2047. AMA supports and encourages the relationship between health2047 and Celgene Corporation, which is working to create solutions for problems related to chronic diseases, data liquidity, and productivity. 

Health2047 with the support of Celgene and tech companies have launched a new spin-out business known as Akiri switch which will transmit secure data among healthcare providers and patients. They are testing solutions and tools at Celgene and other pharmacies. Celgene will keep on working with health2047 on specific issues. 

The article explains the importance of cross-industry collaborations. It also goes through the importance of Celgene and health2047 relationship.

Thanks for joining me!

Good company in a journey makes the way seem shorter. — Izaak Walton